Senior Clinical Program Manager, Clinical Operations

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Adhere to Clinical Standard Operating Procedures (SOP), Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) Guidelines. Be a team leader, providing guidance and oversight for the successful management of all aspects of clinical trials within timelines and designated program budgets. Partner with cross-functional teams to manage, adjust, and revise project timelines and budgets as needed Analyze data health metrics to be shared with stakeholders. Actively partner with cross-functional teams and vendors to drive the query resolution and data listings review process to meet objectives in a timely and efficient process. Conduct risk management, contingency, and scenario planning. Supervise, communicate project status/issues, and problem solve to ensure project team goals are met. Participate in the development of all study-related documentation, including study protocols. Actively contribute in the selection and management of contract research organizations (CROs) and/or vendors, including development of requests for proposals (RFPs). Use all available tools to track, oversee, and communicate on program status to all key stakeholders. Demonstrate the ability to lead and manage multiple complex clinical trials within one or multiple programs with limited oversight. Independently lead Clinical Study Execution Team (CSETs) and influence relevant stakeholders both internally and externally including management. May lead interdepartmental strategic business initiatives as well as spearhead certain SOP development and training. May provide input into strategic and operational short- and long-term therapeutic area development, as appropriate, including supporting alignment and communication to other team members upon implementation Assists in the hiring, development, and retention of top talent within the team. Coach direct report(s) on their performance, development, and career interests. Participate in other Clinical Operations activities as appropriate. Required Skills, Experience and Education: RN or Bachelor’s or Masters degree in biological sciences or health-related field required. 10+ years direct Clinical Operations experience in the pharmaceutical or biotech industry, preferably in Clinical Operations or Clinical Research-related experience. Relevant indirect experiences may also meet the requirement. Minimum of 6 years of cross-functional study management or related leadership experience in life sciences, including multiple years’ experience managing project teams. Strong working knowledge of FDA Regulations, ICH Guidelines, and GCP. Proven ability to successfully start-up, manage, and close-out clinical trials, including authoring clinical study and regulatory documentation and SOPs. Experience in selection of CROs/vendors and management of external resources. Thrives in a collaborative team setting that demonstrates flexibility required to maintain a fast pace and is driven by a desire to deploy innovative approaches and technologies in a high-energy environment. Be solution-oriented by anticipating obstacles and difficulties, and proactively providing risk assessment and mitigation strategies to achieve project goals. Excellent writt